This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Stocks Under $5 Making Big Moves


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

NuPathe (PATH) is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. This stock is trading up 9.2% at $4.01 in recent trading.

Today's Range: $3.76-$4.12

52-Week Range: $1.52-$7.42

Volume: 150,000

Three-Month Average Volume: 30,648

Shares of PATH are moving notably higher today after the company said it expects acceptance of its resubmission of a migraine treatment by the U.S. Food and Drug Administration.

>>5 Biotech Stocks Under $10 Set to Soar

From a technical perspective, PATH is gapping up sharply here with above-average volume. This move is quickly pushing the stock within range of triggering a near-term breakout trade. That trade will hit once PATH takes out some near-term overhead resistance at $4.01 to $4.25 with high volume.

Traders should now look for long-biased trades once PATH sustains a move or close above $4.01 to $4.25 with volume that's near or above 30,648 shares. At last check, PATH has hit an intraday high of $4.01 and volume is well above its three-month average of 30.648 shares. If that breakout triggers soon, then PATH will have a great chance of re-testing and possibly taking out its next major overhead resistance level at $5.10.
3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
PATH $0.00 0.00%
ES $57.86 1.60%
S $3.56 -3.00%
AAPL $94.13 -1.10%
FB $117.61 0.15%


Chart of I:DJI
DOW 17,659.34 -91.57 -0.52%
S&P 500 2,048.00 -15.37 -0.74%
NASDAQ 4,718.88 -44.3440 -0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs